Press release
Latest IDEXX Innovations Designed to Enhance Patient Care and Drive Veterinary Productivity
SediVue Dx® with Advanced Bacteria Detection, new Catalyst® Bile Acids Test, and IDEXX Web PACS™ diagnostic imaging software advancements empower
About this update from Idexx Laboratories, Inc.
[{"type":"text","content":"SediVue Dx® with Advanced Bacteria Detection, new Catalyst® Bile Acids Test, and IDEXX Web PACS™ diagnostic imaging software advancements empower veterinarians for faster, more confident diagnoses\n WESTBROOK, Maine, Jan. 17, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced the latest updates to its SediVue Dx® Urine Sediment Analyzer, Catalyst Dx® and Catalyst One® chemistry analyzers, and IDEXX Web PACS™ cloud-based diagnostic imaging software, expanding the capabilities of each platform. These updates are designed to provide diagnostic tools that enhance patient care and drive productivity for veterinary teams by removing key workflow constraints.\n\n \n \n\n \n\"IDEXX's innovation strategy is focused on advancing veterinary patient care and improving the customer experience,\" said Jay Mazelsky, President and Chief Executive Officer of IDEXX Laboratories. \"These updates target important medical conditions, were influenced by customer input, and are affirmations of our commitment to customers that when they invest in their relationship with IDEXX, we invest in their practice via important ongoing enhancements to their IDEXX technology.\"\nSediVue Dx Urine Sediment Analyzer now with Advanced Bacteria Detection\nThis breakthrough innovation for the SediVue Dx Urine Sediment Analyzer now with Advanced Bacteria Detection will dramatically enhance veterinarians' ability to obtain definitive bacteria results in urine sediment analysis, a core component of a urinalysis. Powered by the world's largest veterinary database of 350 million veterinary patient-generated images, the latest artificial intelligence-based Neural Network software update will enhance the SediVue Dx analyzer's bacteria identification capabilities. And a new proprietary reagent leveraging patent-pending technology will modify a sample and remove clutter from crowded images, enabling veterinarians to obtain conclusive bacteria results with each SediVue Dx run, even in the most clinically challenging samples. \nBacteria can hide behind cells and crystals, or debris in the sample can mimic their appearance, often making bacterial detection the most challenging aspect of urine sediment analysis. Bacteria are the most frequent cause of urinary tract infections, so detection is critica...